1. Home
  2. BAFN vs PSTV Comparison

BAFN vs PSTV Comparison

Compare BAFN & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

N/A

Current Price

$5.78

Market Cap

26.6M

Sector

Finance

ML Signal

N/A

Logo PLUS THERAPEUTICS Inc.

PSTV

PLUS THERAPEUTICS Inc.

HOLD

Current Price

$3.80

Market Cap

27.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAFN
PSTV
Founded
1999
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.6M
27.5M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
BAFN
PSTV
Price
$5.78
$3.80
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$55.00
AVG Volume (30 Days)
17.9K
196.3K
Earning Date
04-30-2026
05-29-2026
Dividend Yield
1.00%
N/A
EPS Growth
N/A
87.61
EPS
N/A
N/A
Revenue
N/A
$5,213,000.00
Revenue This Year
N/A
$13.20
Revenue Next Year
N/A
$261.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.26
$0.13
52 Week High
$15.28
$8.00

Technical Indicators

Market Signals
Indicator
BAFN
PSTV
Relative Strength Index (RSI) 55.97 36.25
Support Level $4.80 $3.70
Resistance Level $5.90 $4.51
Average True Range (ATR) 0.35 0.29
MACD 0.09 0.02
Stochastic Oscillator 81.82 19.89

Price Performance

Historical Comparison
BAFN
PSTV

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Share on Social Networks: